D

OptimizeRx Corporation OPRX

$7.62 $0.060.79% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

OptimizeRx Corporation (NASDAQ: OPRX) is a healthcare technology company focused on digital communication and engagement solutions for the life sciences industry. The company operates within the healthcare information technology, digital therapeutics communication, and pharmaceutical marketing sectors, providing platforms that connect pharmaceutical manufacturers, healthcare providers, patients, and healthcare organizations. Its core offerings are designed to improve patient access, adherence, and engagement through point-of-care messaging, financial assistance information, and omnichannel communication tools integrated into clinical workflows.

The company’s primary revenue drivers include software-enabled marketing services, healthcare provider engagement solutions, patient support communications, and data-driven digital campaigns delivered through electronic health record (EHR) systems and other healthcare technology channels. OptimizeRx serves pharmaceutical companies, biotechnology firms, healthcare providers, and health systems, with a strategic focus on enabling compliant, targeted communication at the point of care. Originally founded in 2006, the company evolved from a patient savings and coupon distribution platform into a broader digital health engagement company through acquisitions, platform expansion, and partnerships with healthcare technology providers.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 13, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)

Price History

Loading...
52-Week Range17% of range
Low
$4.54
Current
$7.62
High
$22.25
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
248 651 6568
Address
260 Charles Street
Suite 302
Waltham, MA 02453
Country
Year Founded

Headlines

9/18/2026 - Seeking Alpha: Editor's Picks